Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Relevance of human fat distribution on lipid and lipoprotein metabolism and cardiovascular disease risk.

Piché ME, Vasan SK, Hodson L, Karpe F.

Curr Opin Lipidol. 2018 Aug;29(4):285-292. doi: 10.1097/MOL.0000000000000522. Review.

PMID:
29994839
2.

Gluteofemoral body fat as a determinant of metabolic health.

Manolopoulos KN, Karpe F, Frayn KN.

Int J Obes (Lond). 2010 Jun;34(6):949-59. doi: 10.1038/ijo.2009.286. Epub 2010 Jan 12. Review.

PMID:
20065965
3.

Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.

Lee MJ, Wu Y, Fried SK.

Mol Aspects Med. 2013 Feb;34(1):1-11. doi: 10.1016/j.mam.2012.10.001. Epub 2012 Oct 13. Review.

4.

Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes.

Karpe F, Pinnick KE.

Nat Rev Endocrinol. 2015 Feb;11(2):90-100. doi: 10.1038/nrendo.2014.185. Epub 2014 Nov 4. Review.

PMID:
25365922
5.

Body composition assessment for the definition of cardiometabolic risk.

Amato MC, Guarnotta V, Giordano C.

J Endocrinol Invest. 2013 Jul-Aug;36(7):537-43. doi: 10.3275/8943. Epub 2013 Apr 23. Review.

PMID:
23612318
6.

Ectopic fat and cardiometabolic and vascular risk.

Lim S, Meigs JB.

Int J Cardiol. 2013 Nov 5;169(3):166-76. doi: 10.1016/j.ijcard.2013.08.077. Epub 2013 Sep 7. Review.

PMID:
24063931
7.

Regional fat distribution and cardiometabolic risk in healthy postmenopausal women.

Peppa M, Koliaki C, Hadjidakis DI, Garoflos E, Papaefstathiou A, Katsilambros N, Raptis SA, Dimitriadis GD.

Eur J Intern Med. 2013 Dec;24(8):824-31. doi: 10.1016/j.ejim.2013.07.001. Epub 2013 Oct 26.

PMID:
24169066
8.

Role of body fat distribution and the metabolic complications of obesity.

Jensen MD.

J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S57-63. doi: 10.1210/jc.2008-1585. Review.

9.

Fat depots, free fatty acids, and dyslipidemia.

Ebbert JO, Jensen MD.

Nutrients. 2013 Feb 7;5(2):498-508. doi: 10.3390/nu5020498. Review.

10.

Detrimental and protective fat: body fat distribution and its relation to metabolic disease.

Booth A, Magnuson A, Foster M.

Horm Mol Biol Clin Investig. 2014 Jan;17(1):13-27. doi: 10.1515/hmbci-2014-0009. Review.

PMID:
25372727
11.

Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans.

Garaulet M, Hernandez-Morante JJ, Lujan J, Tebar FJ, Zamora S.

Int J Obes (Lond). 2006 Jun;30(6):899-905.

PMID:
16446749
12.

Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction.

Bays H.

Curr Opin Endocrinol Diabetes Obes. 2014 Oct;21(5):345-51. doi: 10.1097/MED.0000000000000093. Review.

13.

Genetic aspects of susceptibility to obesity and related dyslipidemias.

Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C.

Mol Cell Biochem. 1992 Aug 18;113(2):151-69. Review.

PMID:
1518506
14.

Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications.

Pinnick KE, Nicholson G, Manolopoulos KN, McQuaid SE, Valet P, Frayn KN, Denton N, Min JL, Zondervan KT, Fleckner J; MolPAGE Consortium, McCarthy MI, Holmes CC, Karpe F.

Diabetes. 2014 Nov;63(11):3785-97. doi: 10.2337/db14-0385. Epub 2014 Jun 19.

15.

Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution.

Tchernof A, Bélanger C, Morisset AS, Richard C, Mailloux J, Laberge P, Dupont P.

Diabetes. 2006 May;55(5):1353-60.

16.

Adiponectin Predicts High-Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat Distribution.

Marsche G, Zelzer S, Meinitzer A, Kern S, Meissl S, Pregartner G, Weghuber D, Almer G, Mangge H.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4117-4123. doi: 10.1210/jc.2017-00933.

PMID:
28938424
17.

Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

Neeland IJ, Poirier P, Després JP.

Circulation. 2018 Mar 27;137(13):1391-1406. doi: 10.1161/CIRCULATIONAHA.117.029617. Review.

18.

Lipid metabolism in women.

Williams CM.

Proc Nutr Soc. 2004 Feb;63(1):153-60. Review.

PMID:
15070445
19.

Cardiovascular risk factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index.

Ramel A, Pumberger C, Martinéz AJ, Kiely M, Bandarra NM, Thorsdottir I.

Nutr Res. 2009 May;29(5):305-12. doi: 10.1016/j.nutres.2009.05.004.

PMID:
19555811
20.

Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.

Peppa M, Koliaki C, Papaefstathiou A, Garoflos E, Katsilambros N, Raptis SA, Hadjidakis DI, Dimitriadis GD.

Obesity (Silver Spring). 2013 Sep;21(9):1807-14. doi: 10.1002/oby.20227. Epub 2013 May 21.

Supplemental Content

Support Center